BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10885905)

  • 1. Apoptosis induction and cell cycle perturbation in human hepatoma hep G2 cells by 10-hydroxycamptothecin.
    Zhang XW; Qing C; Xu B
    Anticancer Drugs; 1999 Jul; 10(6):569-76. PubMed ID: 10885905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of phosphorylation of histone H1 and H3 induced by 10-hydroxycamptothecin, DNA topoisomerase I inhibitor, in murine ascites hepatoma cells.
    Ling YH; Xu B
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):546-50. PubMed ID: 8010056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of P53, c-Myc, Bcl-2, Bax and AFP protein expression, and caspase activity during 10-hydroxycamptothecin-induced apoptosis in Hep G2 cells.
    Zhang XW; Xu B
    Anticancer Drugs; 2000 Oct; 11(9):747-56. PubMed ID: 11129738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation-inducing action of 10-hydroxycamptothecin on human hepatoma Hep G2 cells.
    Zhang XW; Jiang JF; Xu B
    Acta Pharmacol Sin; 2000 Apr; 21(4):364-8. PubMed ID: 11324469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of hydroxycamptothecin on laryngeal squamous carcinoma cell line].
    Chai LP; Su ZZ; Xian ZX
    Ai Zheng; 2003 Apr; 22(4):372-5. PubMed ID: 12703991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antitumor effects of ring-closed and ring-opened hydroxycamptothecin on oral squamous carcinoma cell line Tca8113].
    Wang AX; Li S; Ding XQ; Chen Y; Chen D
    Ai Zheng; 2005 Aug; 24(8):970-4. PubMed ID: 16086875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer effects of low-dose 10-hydroxycamptothecin in human colon cancer.
    Ping YH; Lee HC; Lee JY; Wu PH; Ho LK; Chi CW; Lu MF; Wang JJ
    Oncol Rep; 2006 May; 15(5):1273-9. PubMed ID: 16596197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of human hepatoma Hep G2 cells induced by 10-hydroxycamptothecin.
    Zhang X; Zhou Y; Xu B
    Chin Med J (Engl); 2000 Aug; 113(8):712-3. PubMed ID: 11776054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways.
    Liu W; Zhang R
    Int J Oncol; 1998 Apr; 12(4):793-804. PubMed ID: 9499438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxycamptothecin-induced apoptosis in hepatoma SMMC-7721 cells and the role of mitochondrial pathway.
    Fu YR; Yi ZJ; Yan YR; Qiu ZY
    Mitochondrion; 2006 Aug; 6(4):211-7. PubMed ID: 16926123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
    Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
    J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis in human cancer cells by TZT-1027, an antimicrotubule agent.
    Watanabe J; Natsume T; Fujio N; Miyasaka K; Kobayashi M
    Apoptosis; 2000 Oct; 5(4):345-53. PubMed ID: 11227216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor effect of (S)-10-hydroxycamptothecin on mouse hepatoma BW7756 and its possible mode of action.
    Tsou KC; Xu B; Miller EE; Lo KW
    Anticancer Res; 1981; 1(2):115-9. PubMed ID: 7347154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of hydroxycamptothecin in the activity of RNA and DNA polymerases prepared from murine hepatoma cells.
    Xu B; Ling YH
    Am J Chin Med; 1985; 13(1-4):23-31. PubMed ID: 4025212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines.
    Ng LT; Chiang LC; Lin YT; Lin CC
    Am J Chin Med; 2006; 34(1):125-35. PubMed ID: 16437745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of hydroxycamptothecin and topotecan to SKOV3 and CAOV3 in vitro].
    Sun Z; Shen K; Xu X
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):547-50. PubMed ID: 11360641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
    Ling YH; Andersson BS; Nelson JA
    Cancer Biochem Biophys; 1990 Jan; 11(1):23-30. PubMed ID: 2159843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition and apoptosis induction in human hepatoma cells by tanshinone II A.
    Tang Z; Tang Y; Fu L
    J Huazhong Univ Sci Technolog Med Sci; 2003; 23(2):166-8, 172. PubMed ID: 12973939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticancer effect of hydroxycampothecin on oral squamous carcinoma cell line].
    Ding XQ; Wang AX; Kong QY; Chen HZ; Chen Y
    Ai Zheng; 2002 Apr; 21(4):388-91. PubMed ID: 12452017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of DNA topoisomerase I inhibitor, 10-hydroxycamptothecin, on the structure and function of nuclei and nuclear matrix in bladder carcinoma MBT-2 cells.
    Ling YH; Perez-Soler R; Tseng MT
    Anticancer Res; 1993; 13(5A):1613-7. PubMed ID: 8239542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.